Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: October 9, 2001
Last updated: September 21, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2004
  Estimated Primary Completion Date: No date given